Effects of Pilate Versus Aerobic Exercises on Dyspnea , Functional Capacity and Anxiety Status in Patients With COPD

Not Applicable

Recruiting

• Conditions: COPD Patients
• Interventions: Other: Pilates Exercises; Other: Aerobic Exercises

• Registration Number: NCT06479499
• Lead Sponsor: Riphah International University

Brief Summary

This study aims to compare the effects of Pilates, with its emphasis on proper breathing and muscle activation, and aerobic exercises, known for improving cardiovascular fitness, on dyspnea, anxiety, and functional capacity in COPD patients.

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) poses a significant public health burden, with rising mortality rates and increased disability-adjusted life years. Common symptoms include dyspnea, chronic cough, and chest tightness, often exacerbated by factors like cigarette smoke and air pollution. Functional capacity becomes a notable concern, marked by exercise intolerance and muscle deconditioning due to COPD's characteristic airflow limitation. Anxiety, linked to breathlessness and the chronic nature of COPD, further complicates the interplay, restricting functional capacity and social involvement. Holistic management, including pulmonary rehabilitation, recognizes these challenges. This study aims to compare the effects of Pilates, with its emphasis on proper breathing and muscle activation, and aerobic exercises, known for improving cardiovascular fitness, on dyspnea, anxiety, and functional capacity in COPD patients.

Participants in a research study will be informed and provide voluntary consent before undergoing an 8-week intervention involving Pilates or aerobic exercise, alongside conventional treatments. The study aims to improve respiratory function and overall well-being, with data collected on demographics, primary, and secondary outcomes. Statistical analysis, conducted using SPSS, will include descriptive statistics, paired sample t-tests and Man Witney test. The study adheres to ethical guidelines, ensuring participant rights and welfare. Overall, it seeks to comprehensively analyze the impact of exercise interventions on respiratory health and quality of life through rigorous statistical methods and visualization.

Study Timeline

• Study Start: 2023-11-23
• Status Verified: 2024-06
• Primary Completion: 2024-06-18
• Study Completion: 2024-06-18
• Study First Submitted: 2024-06-24
• Study First Submitted QC: 2024-06-24
• Last Update Submitted: 2024-06-24
• Study First Posted: 2024-06-28
• Last Update Posted: 2024-06-28

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• The both male and female participants will be included in the study.
• The age of included participants will be 45-65 years old.
• Diagnosed COPD patients of stage 2-3 according to gold criteria (moderate)
• When the patients started the exercise program, they were stable, and none of them showed any clinical signs of neuromuscular or cardiovascular conditions that would prevent them from exercising.
• The selected participants are getting medical therapy with pulmonary medications.
• Those participants who will sign a written informed consent form will be included in the study.

Read More

Exclusion Criteria

• Participants who had recent abdominal and chest surgeries will be excluded.
• Patients having history of cardiac arrhythmias or potential ECG alterations,
• Patients who are unable to follow commands.
• Participants presented with severe neuro-musculoskeletal abnormalities.
• The chosen individuals were smokers or former smokers with a medical history of COPD; none of them exhibited any physiological or clinical signs of bronchial asthma.
• No involvement in a consistent workout regimen for a minimum of six months before the study's start.
• Those participants who are doing Yoga.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Pilates exercises	Pilates Exercises	Group A will receive Pilates exercise with duration of 10-15 minutes and gradually progressing to 20-30 minutes. The session will hold 3 times per week over period of 8 weeks. It begins with warm-up and cool-down of about 5-10 minutes with rest interval of 1-2 minutes.
Aerobic exercise	Aerobic Exercises	Group B will receive aerobic exercise it begins with a warm-up of 5-10 minutes. The duration of session will be 5-10 minutes in short interval of 1-2 minutes and then gradually reducing it to 30 seconds. The cool-down will be 5-10 minutes. The session will hold 3 times per week over period of 8 weeks.

Primary Outcome Measures

Name	Time	Method
Dyspnea	8th weeks	The modified Medical Research Council scale (mMRC scale) is largely used in the assessment of dyspnea in chronic respiratory diseases. The mMRC scale is a 5-point (0-4) scale based on the severity of dyspnea. It is a quantitative assessment tool only for breathlessness. It assesses the effectiveness of treatment on an individual bass. Compare the effectiveness of a treatment within a population and Predict survival times and rates.
Anxiety	8th weeks	The Self rating anxiety scale is a 20-item self-report assessment device built to measure anxiety levels, based on scoring in 4 groups of manifestations: cognitive, autonomic, motor and central nervous system symptoms. Answering the statements, a person should indicate how much each statement applies to him or her within a period of one or two weeks prior to taking the test. Each question is scored on a Likert-type scale of 1-4 (based on these replies: "a little of the time", "some of the time", "good part of the time", "most of the time"). Some questions are negatively worded to avoid the problem of set response. Overall assessment is done by total score.
Functional Capacity	8th weeks	In the context of COPD functional capacity refers to a person's ability to perform daily activities and exercise without experiencing excessive shortness of breath or fatigue. It is an important measure to assess the function of a person with COPD therefore in present study it will be assessed by 6 minutes' walk distance.

Trial Locations

Locations (1)

Riphah international university; 🇵🇰 Lahore, Punjab, Pakistan